TGF-β1 and VEGF as biomarkers for renal scarring in children with vesicoureteral reflux
| dc.contributor.author | Morozova, O. | |
| dc.contributor.author | Makieieva, N. | |
| dc.date.accessioned | 2019-12-01T17:15:18Z | |
| dc.date.available | 2019-12-01T17:15:18Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | One of the most common forms of congenital obstructive uropathy in children is vesicoureteral reflux (VUR), which is observed in 1-2% of pediatric population, and its incidence in urinary tract infection is 70%. According to the International Committee for the Study of Reflux, the incidence of nephrosclerosis in VUR among children of the European population is 48% and it results in the development of the terminal stage of chronic renal failure in 25-60% of patients. Approximately 25% of children with renal scarring (RS) caused by VUR require hemodialysis and kidney transplantation. | ru_RU |
| dc.identifier.citation | Morozova O. TGF-β1 and VEGF as biomarkers for renal scarring in children with vesicoureteral reflux / O. Morozova, N. Makieieva // Nephrology Dialysis Transplantation. ‒ 2019. ‒ Vol. 34, Issue Suppl. 1 : 56-th ERA-EDTA Congress, Hungary, 13‒16 June 2019. ‒ FP812. ‒ DOI: https://doi.org/10.1093/ndt/gfz106.FP812. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/25145 | |
| dc.language.iso | en | ru_RU |
| dc.subject | chronic kidney disease | ru_RU |
| dc.subject | children | ru_RU |
| dc.title | TGF-β1 and VEGF as biomarkers for renal scarring in children with vesicoureteral reflux | ru_RU |
| dc.type | Article | ru_RU |